Phase II clinical trial of OKT3 for acute graft-versus-host disease (GVHD) prophylaxis in allogeneic bone marrow transplantation (alloBMT).

被引：0
|
作者：
Alam, A [1 ]
Baer, MR [1 ]
Bernstein, S [1 ]
Bernstein, Z [1 ]
Christiansen, N [1 ]
Czuczman, M [1 ]
Schriber, J [1 ]
Slack, J [1 ]
Tezcan, H [1 ]
Wetzler, M [1 ]
Cooper, M [1 ]
Milk, B [1 ]
Ford, L [1 ]
Herzig, G [1 ]
McCarthy, P [1 ]
机构：
[1] ROSWELL PK CANC INST,BUFFALO,NY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：449 / 449
页数：1
相关论文
共 50 条
  • [41] Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease
    T Nishida
    M Hamaguchi
    N Hirabayashi
    M Haneda
    S Terakura
    Y Atsuta
    S Imagama
    T Kanie
    M Murata
    H Taji
    R Suzuki
    Y Morishita
    Y Kodera
    Bone Marrow Transplantation, 2004, 33 : 1143 - 1150
  • [42] ATTEMPTS AT T-CELL DEPLETION USING OKT3 AND RABBIT COMPLEMENT TO PREVENT ACUTE GRAFT VERSUS HOST-DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BLACKLOCK, HA
    PRENTICE, HG
    GILMORE, MJML
    PRICEJONES, E
    SCHEY, S
    TIDMAN, N
    MA, DDF
    GOLDSTEIN, G
    JANOSSY, G
    HOFFBRAND, AV
    EXPERIMENTAL HEMATOLOGY, 1983, 11 : 37 - 39
  • [43] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL AND CLINICAL BONE-MARROW TRANSPLANTATION
    TUTSCHKA, PJ
    PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1985, 6 (02): : 257 - 274
  • [44] Evaluation of the prophylactic effect of graft-versus-host disease (GVHD) from allogeneic bone marrow transplantation by ursodeoxycholic acid.
    Iwata, N
    Kuroiwa, T
    Kataoka, Y
    Nakata, A
    Seto, Y
    Takemoto, Y
    Kakishita, E
    HEPATOLOGY, 1998, 28 (04) : 443A - 443A
  • [45] INDIRECT ASSOCIATION OF ELEVATED SERUM IGE AND GRAFT-VERSUS-HOST DISEASE (GVHD) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    DONNENBERG, AD
    HEYD, J
    BURNS, WH
    SARAL, R
    SANTOS, GW
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 517 - 517
  • [46] Does oxypentifylline reduce the intensity of acute graft-versus-host disease following allogeneic bone marrow transplantation?
    Ghosh, K
    Hutchinson, RM
    HAEMATOLOGIA, 1996, 28 (01) : 45 - 51
  • [47] ENDOSCOPIC DIAGNOSIS AND GRADING OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KREISEL, W
    HERBST, EW
    GEROK, W
    FAUSER, AA
    GASTROENTEROLOGY, 1994, 106 (04) : A715 - A715
  • [48] EFFECT OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) ON OUTCOME OF BONE-MARROW TRANSPLANTATION IN ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    FEIG, SA
    NESBIT, ME
    BUCKLEY, J
    LAMPKIN, B
    BERNSTEIN, I
    KIM, T
    PIOMELLI, S
    KERSEY, J
    COCCIA, P
    OREILLY, RJ
    AUGUST, C
    THOMAS, ED
    HAMMOND, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 217 - 217
  • [49] DIAGNOSIS AND GRADING OF ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BY SIGMOIDOSCOPY
    KREISEL, W
    HERBST, EW
    SCHWIND, B
    OCHS, A
    OLSCHEWSKI, M
    KOCHLING, G
    FAUSER, AA
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (08) : 723 - 729
  • [50] BULLOUS PEMPHIGOID ASSOCIATED WITH ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    DELBALDO, C
    RIECKHOFFCANTONI, L
    HELG, C
    SAURAT, JH
    BONE MARROW TRANSPLANTATION, 1992, 10 (04) : 377 - 379
12345